Aller au contenu principal
2023 conference-abstract

3: Determinants of parenteral nutrition (PN) weaning in a pediatric cohort of short bowel syndrome (SBS) patients in the era of GLP-2 analogue treatment

1Citations signalées — pas une note de qualité
4Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Introduction: SBS is the main cause of chronic intestinal failure. New treatments such as GLP-2 analogues aim at improving intestinal mucosal trophicity and absorption while reducing PN dependence. The aim was to identify the factors determining PN weaning in children with SBS. Methods: A monocentric retrospective study involved all SBS children followed between 2015 and 2020. PN dependence was defined as non-protein PN calories (kcal/day)/ REE (kcal/day, from Schofield). Statistical analysis included non-parametric tests, Mann-Whitney and Chi-2 for quantitative and qualitative variables respectively, and a multivariate Cox model. Results were expressed as median and IQR. Results: We included 137 patients with a median age at start of follow-up of 3.7 years (IQR 1.3-8.4). SBS types: 30% jejunostomy or ileo-rectal anastomosis (type 1), 41% jejuno-colic anastomosis (type 2) and 29 % jejuno-ileal anastomosis (type 3). The median length of the remaining SB was 50 cm (IQR 27-73). The main causes for SBS were: midgut volvulus (23.4%), necrotizing enterocolitis (22.6%), long-segment Hirschsprung disease (21.2%), gastroschisis (15.3%) and atresia (13.1%). The median PN dependence at inclusion was 104 % (IQR 80-122) and 83 % (IQR 50-111) at the end. Thirty patients received Teduglutide (TED) at 0.05mg/kg/day, from a median age of 8.5 yrs (IQR 7.2-11.0). The median treatment duration was 36 months (IQR 33-39); 27 patients were still treated at the end of follow-up. Fifty-five patients (40%) were weaned during the follow-up. Factors positively associated with PN weaning were: length of remaining SB (p<0.001) and TED treatment (p=0.05). Initial PN dependence was negatively associated with weaning (p<0.001), as well as SBS type 1 (p=0.04). Conclusion: As expected, SB length and the presence of colon were predictive factors for PN-weaning. Teduglutide becomes one of the factors positively associated with weaning. It should be considered in SBS but timing remains debated.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
3: Determinants of parenteral nutrition (PN) weaning in a pediatric cohort of short bowel syndrome (SBS) patients in the era of GLP-2 analogue treatment
Date Crossref
27/06/2023
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Clinical Nutrition and GastroenterologyIntestinal Malrotation and Obstruction DisordersChild Nutrition and Feeding Issues

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.